Alexza Pharmaceuticals - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsAlexza Pharmaceuticals

Alexza Pharmaceuticals(ALXA)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Adasuve	Loxapine	2012-12-21	2024-2026	Schizophrenia , Psychotic disorders , Bipolar disorder

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

,

,

chronic obstructive pulmonary disease

,

,

obstructive lung diseases

,

cigarette smoking

,

migraine disorders

,

,

,

psychomotor agitation

,

bipolar disorder

,

healthy volunteers/patients

healthy volunteers/patients

,

type 2 diabetes mellitus

,

,

,

,

non-small-cell lung carcinoma

,

,

respiratory syncytial virus infections

,

brain neoplasms

,

central nervous system neoplasms

,

,

glucose metabolism disorders

,

metabolic diseases

,

alzheimer disease

,

huntington disease

,

thyroid neoplasms

,

,

sickle cell anemia

,

atopic dermatitis

,

,

colorectal neoplasms

,

anxiety disorders

,

prostatic neoplasms

,

breast neoplasms

,

,

adenocarcinoma of lung

,

generalized anxiety disorder

,

reflex epilepsy

,

bipolar disorder

,

diabetes mellitus

,

,

status epilepticus

,

critical illness

,

,

psychomotor agitation

,

post-traumatic stress disorders

,

executive function

,

,

partial epilepsies

,

generalized epilepsy

,

complex partial epilepsy

,

,

insulin resistance

,

metabolic syndrome

,

,

major depressive disorder

,

depressive disorder

,

psychotic disorders

,

gastrointestinal endoscopy

,

hyperlipidemias

,

renal cell carcinoma

,

prostatic neoplasms

,

pancreatic neoplasms

,

non-small-cell lung carcinoma

,

triple negative breast neoplasms

,

head and neck neoplasms

,

non-hodgkin lymphoma

,

,

,

large b-cell lymphoma diffuse

Histone-arginine methyltransferase carm1

healthy volunteers/patients

,

,

follicular lymphoma

,

large b-cell lymphoma diffuse

,

non-hodgkin lymphoma

,

,

non-small-cell lung carcinoma

,

liver neoplasms

,

urologic neoplasms

,

urinary bladder neoplasms

,

transitional cell carcinoma

,

diabetes mellitus

,

rheumatoid arthritis

,

kidney diseases

,

kidney transplantation

,

breast neoplasms

,

,

,

hepatocellular carcinoma

,

,

b-cell chronic lymphocytic leukemia

,

lymphoid leukemia

,

,

esophageal neoplasms

,

biliary tract neoplasms

,

rectal neoplasms

,

,

small cell lung carcinoma

,

castration-resistant prostatic neoplasms

,

,

,

type 2 diabetes mellitus

,

,

brain neoplasms

,

hematologic neoplasms

,

lymphoproliferative disorders

,

neoplasms by histologic type

,

neoplasms by site

,

multiple myeloma

,

plasma cell neoplasms

,

colorectal neoplasms

,

,

disability evaluation

,

cognition disorders

,

,

,

,

chronic hepatitis b

,

chronic hepatitis

,

,

,

multiple sclerosis

,

,

papillomavirus infections

,

papillomaviridae

,

uterine cervical neoplasms

healthy volunteers/patients

,

,

community-acquired infections

,

bacterial pneumonia

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use